Stryker SG&A increased by 2.4% to $2.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.8%, from $2.30B to $2.28B. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 7.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 11, 2026
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
Metric ID:
selling_general_and_administrativeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.51B | $1.60B | $1.75B | $1.71B | $1.54B | $1.46B | $1.68B | $1.78B | $1.71B | $1.71B | $1.91B | $1.84B | $1.83B | $1.89B | $2.12B | $2.30B | $2.08B | $2.05B | $2.23B | $2.28B |
| QoQ Change | — | +6.4% | +8.9% | -2.0% | -10.0% | -5.5% | +15.6% | +5.9% | -4.0% | +0.1% | +11.8% | -3.9% | -0.3% | +3.4% | +12.1% | +8.3% | -9.6% | -1.6% | +8.9% | +2.4% |
| YoY Change | — | — | — | — | +2.3% | -9.2% | -3.6% | +4.2% | +11.0% | +17.5% | +13.6% | +3.1% | +7.1% | +10.8% | +11.1% | +25.2% | +13.5% | +8.0% | +4.9% | -0.8% |
Range$1.46B – $2.30B
CAGR+9.1%
Avg YoY Growth+7.4%
Median YoY Growth+7.6%
Current Streak2 quarters growth
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| MedSurg and Neurotechnology: | $859.00M | $984.00M | $972.00M | $1.04B | $930.00M |
| Orthopaedics | $925.00M | — | — | — | — |
| Total | $2.30B | $2.08B | $2.05B | $2.23B | $2.28B |
SG&A at Other Companies
Frequently Asked Questions
- What is Stryker's sg&a?
- Stryker (SYK) reported sg&a of $2.28B in Q1 2026.
- How has Stryker's sg&a changed year-over-year?
- Stryker's sg&a decreased by 0.8% year-over-year, from $2.30B to $2.28B.
- What is the long-term trend for Stryker's sg&a?
- Over 4 years (2021 to 2025), Stryker's sg&a has grown at a 7.7% compound annual growth rate (CAGR), from $6.43B to $8.65B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.